HOME >> BIOLOGY >> NEWS
Plant-cell-produced technologies-cutting edge approach to bringing solutions to the market

Indianapolis/Brussels: Four months after the world's first vaccine made in plant cells has received regulatory approval in the US, Dow AgroSciences is organising a Science Conference in Brussels on 7 June 2006 in order to share this knowledge with European researchers, scientists, decision-makers and industry representatives.

The pioneering vaccine developed by Dow AgroSciences works against the Newcastle disease virus (NDV) in poultry. The latest technology could be applied quite quickly to other diseases - with avian flu a prime target. This approval represents an innovative milestone for the company and the industry.

The Dow AgroSciences Concert Plant-Cell-Produced System represents a new category of plant-made vaccines. This leading edge technology utilises plant cells instead of whole plants in a secure, bio-contained environment to produce vaccines. Because of this bio-contained production system, concerns and challenges associated with making vaccines in whole plants or food crops are eliminated. The Concert Plant-Cell-Produced System uses only the necessary parts of the disease causing agent to stimulate immunity in a manufacturing process that is totally free of animal components: "Being the first company to ever register a plant-made vaccine is another example of Dow AgroSciences' cutting edge approach to bringing highly novel and differentiated solutions to the market," said Jerome Peribere, Dow AgroSciences' president and CEO.

The conference on 7 June, entitled "Innovations in Biosciences for Animal and Human Health" will highlight major bioscience developments and scientific solutions that could prevent diseases and reduce animal and human health risks in Europe. Dow AgroSciences President and Chief Executive Officer Mr. Jerome A. Peribere will deliver a welcome address. Dow AgroSciences's R&D capability will be presented by Mr. Antonio Galindez, (Dow AgroSciences Vice President, Europe, Latin America, Pacific) and Dr. Dan Kit
'"/>

Contact: Marta Czerniawska
marta@isc-europe.com
032-401-6147
ISC
31-May-2006


Page: 1 2

Related biology news :

1. Researchers use new approach to predict protein function
2. New approach to pulmonary hypertension shows promise
3. Personalized approach to ovarian stimulation achieves high ART pregnancy rates
4. New approaches to endometriosis treatment -- mouse experiments point the way
5. Reconstructing the biology of extinct species: A new approach
6. Screening approach leads to discovery of gene linked to breast cancer
7. In new statistical approach, data decide model
8. Bigelow Laboratory Scientists develop new approach to study marine microbes
9. New understanding of schizophrenia could lead to new treatment approaches
10. Cheaper, better disease treatments expected from faster approach to developing antibodies
11. New imaging approach promises insights into multiple sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... (PRWEB) , ... July 01, 2020 , ... ... building awareness and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced ... Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s initiatives and ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... services, today announced that the company has received ISO9001:2015 certification for the ... and research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s commitment ...
(Date:6/23/2020)... ... June 23, 2020 , ... In its June 22 online post, business and ... L. Sherley, M.D., Ph.D., founder and director of stem cell biotechnology company Asymmetrex ... 16 that starting July 5 it would begin offering free tissue stem ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... ... Eaton Square is pleased to announce its growth on the East Coast ... technology-focused strategy and M&A advisory firm. , This is an important step for Eaton ... Pacific healthcare innovators with capital and investors. , Popper and Company, founded in 2003 ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... (hMSC) working cell banks and hMSC bioprocess systems, today announced the launch ... of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with ...
(Date:5/15/2020)... ... May 14, 2020 , ... This new service offers clients a ... pressing questions answered quickly as the need arises. Lachman’s OnCall SMEs have extensive knowledge ... affordable rates. , Lachman OnCall™ SMEs are available normal business hours Monday through ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... the new distribution partner for all personal care ingredients in Russia and Belarus. ... DuPont preservative portfolio for personal care. , The GENENCARE®OSMS product line ...
Breaking Biology Technology:
Cached News: